Company Overview and News


Add ADR
to your dashboard

Headline News

Adherium granted U.S. patent for medication adherence device

2016-10-20 proactiveinvestors.com.au
The company has developed ‘Smartinhaler’, which is a touch-enabled device that provides alerts to improve medication adherence and health outcomes for patients. Clinical evidence shows that using Smartinhaler technology in asthma substantially increases adherence to preventative medications and reduces severe exacerbations in adults and children. The U.S. patent is the first to be issued in a planned suite of patents related to medication adherence monitoring devices that include an optical dose counter.

Adherium Ltd partners with AstraZeneca to improve medication adherence

2016-08-16 proactiveinvestors.com.au
Adherium Ltd (ASX:ADR) is focussed on digital health technologies which address sub optimal medication use in chronic disease.

Adherium Ltd's technology used in AstraZeneca chronic respiratory disease study

2016-06-14 proactiveinvestors.com.au
Adherium Ltd (ASX:ADR) is focussed on digital health technologies which address sub optimal medication use in chronic disease.

Adherium Ltd's technology used in AstraZeneca chronic respiratory disease clinical study

2016-06-14 proactiveinvestors.com.au
Adherium Ltd (ASX:ADR) is focussed on digital health technologies which address sub optimal medication use in chronic disease.

Appendix 4C - quarterly

2016-04-29 asx.com.au

Details of Company Address

2016-03-31 asx.com.au

Appendix 3B

2016-03-30 asx.com.au

Becoming a substantial holder

2016-03-30 asx.com.au

Appendix 3B

2016-03-18 asx.com.au

Appendix 3B

2016-03-04 asx.com.au

Becoming a substantial holder

2016-02-15 asx.com.au

Appendix 4C - quarterly

2016-01-28 asx.com.au